Palladini, Giovanni http://orcid.org/0000-0001-5994-5138
Paiva, Bruno http://orcid.org/0000-0003-1977-3815
Wechalekar, Ashutosh
Massa, Margherita
Milani, Paolo
Lasa, Marta
Ravichandran, Sriram http://orcid.org/0000-0001-5650-0088
Krsnik, Isabel
Basset, Marco
Burgos, Leire
Nuvolone, Mario
Lecumberri, Ramón
Foli, Andrea
Puig, Noemi
Sesta, Melania Antonietta
Bozzola, Margherita
Cascino, Pasquale
Nevone, Alice
Ripepi, Jessica
Berti, Pierpaolo http://orcid.org/0000-0003-0512-2704
Casarini, Simona http://orcid.org/0000-0003-4730-7467
Annibali, Ombretta
Orfao, Alberto http://orcid.org/0000-0002-0007-7230
San-Miguel, Jesus http://orcid.org/0000-0002-9183-4857
Merlini, Giampaolo http://orcid.org/0000-0001-7680-3254
Funding for this research was provided by:
International Myeloma Society - Bart Barlogie Young Investigator Award
Collegio Ghislieri di Pavia
Article History
Received: 9 June 2020
Revised: 17 October 2020
Accepted: 2 November 2020
First Online: 16 February 2021
Conflict of interest
: G.P. reports honoraria for lectures from and membership on advisory boards with Jannsen-Cilag. B.P. reports honoraria for lectures from and membership on advisory boards with Amgen, Bristol-Myers Squibb, Celgene, Janssen-Cilag, Merck, Novartis, Roche, and Sanofi; unrestricted grants from Celgene, EngMab, Sanofi, and Takeda; and consultancy for Celgene, Janssen, and Sanofi; P.M. reports honoraria for lectures from Pfizer, Jannsen-Cilag, and travel support from Celgene; M.N. reports honoraria for lectures from Jannsen-Cilag; and R.L. received lecture fees from Jannsen-Cilag.